There’s a standard response when people feel the sticker shock at seeing the prices on brand new drugs: that cost is necessary to subsidize the expense of drug development. And that’s true! Bringing a new drug to market takes a lot of time and money and multiple levels of testing and clinical trials. It hurts to pay it, but you’re paying all the costs of development (would that companies that tear up the environment had to obey the same principle).
But now Martin Shkreli comes along, and ruins the whole defense. Shkreli bought the rights to a drug, Daraprim, and immediately jacked up the cost from $13.50/pill to $750/pill, all for a drug that cost him $1/pill to manufacture.







